These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 300626)

  • 81. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
    Carlsten H; Holmdahl R; Tarkowski A
    Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The effects of PGE1 on lymphocytes in NZB/W mice.
    Winkelstein A; Kelley VE
    Clin Immunol Immunopathol; 1980 Oct; 17(2):212-18. PubMed ID: 6447567
    [No Abstract]   [Full Text] [Related]  

  • 84. Effect of PGE1 treatment on in vitro thymocyte function of normal and autoimmune mice.
    Whittum-Hudson J; Ballow M; Zurier RB
    Immunopharmacology; 1988; 16(2):71-8. PubMed ID: 2974449
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prostaglandin E1 treatment of NBZ/W F1 hybrids--induction of in vitro and in vivo cell-mediated immune response to DNA.
    Adelman N; Ksiazek J; Cohen S; Yoshida T; Zurier RB
    Clin Immunol Immunopathol; 1980 Nov; 17(3):353-62. PubMed ID: 7000403
    [No Abstract]   [Full Text] [Related]  

  • 86. Age-related changes in lymphoid tissue content of prostaglandins in (NZB X NZW)F1 and CBA/H mice.
    Calvano SE; Mark DA; Good RA; Fernandes G
    Arthritis Rheum; 1983 Jan; 26(1):113-6. PubMed ID: 6824500
    [No Abstract]   [Full Text] [Related]  

  • 87. Antinephritic effect of prostaglandin E1 on serum sickness nephritis in rats (4). Enhanced clearance of macromolecules by the reticulo-endothelial system with prostaglandin E1.
    Nagamatsu T; Suzuki Y
    Jpn J Pharmacol; 1987 Jul; 44(3):369-72. PubMed ID: 3656790
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Safety assessment of poly I:C in NZB/NZW mice (38565).
    Mendlowski B; Field AK; Tytell AA; Hilleman MR
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):476-83. PubMed ID: 1121498
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice.
    Frolov A; Yang L; Dong H; Hammock BD; Crofford LJ
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):351-8. PubMed ID: 24055573
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2.
    Levin G; Duffin KL; Obukowicz MG; Hummert SL; Fujiwara H; Needleman P; Raz A
    Biochem J; 2002 Jul; 365(Pt 2):489-96. PubMed ID: 11939906
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Attenuation of immune complex nephritis in NZB/WF1 mice by a prostacyclin analogue.
    Utsunomiya Y; Ogura M; Kawamura T; Mitarai T; Maruyama N; Sakai O
    Clin Exp Immunol; 1995 Mar; 99(3):454-60. PubMed ID: 7882569
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.
    Strassmann G; Patil-Koota V; Finkelman F; Fong M; Kambayashi T
    J Exp Med; 1994 Dec; 180(6):2365-70. PubMed ID: 7525853
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.
    Prickett JD; Robinson DR; Steinberg AD
    J Clin Invest; 1981 Aug; 68(2):556-9. PubMed ID: 7263863
    [TBL] [Abstract][Full Text] [Related]  

  • 94. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in kidney tissue from NZB/NZW F1 hybrid mice.
    Casey ML; Hurd ER; Gilliam JN; MacDonald PC; Johnston JM
    Immunology; 1982 Jan; 45(1):23-6. PubMed ID: 7056565
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Late treatment of murine lupus erythematosus with dactinomycin. II. C1 and antibody to DNA.
    Olsen CT; Teague PO; Gabrielsen AE
    Immunology; 1981 Jun; 43(2):213-7. PubMed ID: 6972907
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet.
    Hurd ER; Johnston JM; Okita JR; MacDonald PC; Ziff M; Gilliam JW
    J Clin Invest; 1981 Feb; 67(2):476-85. PubMed ID: 6450777
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Suppression of autoimmune diseases with anti-idiotypic antibodies: murine lupus nephritis as a model.
    Hahn BH
    Springer Semin Immunopathol; 1984; 7(1):25-34. PubMed ID: 6377539
    [No Abstract]   [Full Text] [Related]  

  • 98. Regulation of the immune response by prostaglandins.
    Goodwin JS; Ceuppens J
    J Clin Immunol; 1983 Oct; 3(4):295-315. PubMed ID: 6140268
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice.
    Tarkowski A; Gunnarsson K; Stålhandske T
    Immunology; 1986 Dec; 59(4):589-94. PubMed ID: 3804379
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of prostaglandin E2 on disease activity, gastric secretion and intestinal permeability, and morphology in patients with rheumatoid arthritis.
    Henriksson AE; Tagesson C; Uribe A; Uvnäs-Moberg K; Nord CE; Gullberg R; Johansson C
    Ann Rheum Dis; 1988 Aug; 47(8):620-7. PubMed ID: 3166369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.